City Therapeutics is preparing for a U.S. IPO to raise funds for its RNAi therapeutic pipeline, including its lead candidate CITY-FXI aimed at treating thrombosis. The company has shown promising early Phase 1 results and benefits from strong partnerships with major pharmaceutical companies and experienced leadership. Proceeds from the IPO will support ongoing clinical trials, pipeline development, and platform advancement, with an expected cash runway of about 18 months. While risks include trial failure and regulatory delays, current market sentiment and investor backing are favorable for the IPO.
City Therapeutics' IPO plans provide context for health-sector market data from Pluang as of Sep 29, 2026 19:14 WIB. Of 100 priced health-sector US stocks tradable on Pluang, 50 rose and 41 fell today. Notable movers include SANA at USD 2.99 with a 1-day change of +2.05%, ADPT at USD 29.06 with a 1-day change of +1.93%, and CYTK at USD 67.24 with a 1-day change of +1.63%.
CarMax reported an 81.3% increase in second-quarter diluted earnings per share to $1.16, driven by a 13.8% rise in retail used vehicle sales and a 32.1% increase in auto finance income. Despite pricing actions that lowered gross profit per vehicle by...
Anthropic is preparing for an IPO with a record $2 trillion valuation, aiming to be the first pure AI company on the market. Despite a massive revenue surge of over 1,000% from 2024 to 2025, the company reported a $42 billion loss, including a $34 bi...
Three public companies—Bath & Body Works, Wendy's, and Yelp—are identified as attractive buyout candidates due to steady cash flow, equity discounts, and operational improvements. Bath & Body Works offers strong cash flow but has balance sheet challe...
Vuzix Corporation introduced the Shrike, a configurable waveguide display platform designed for defense, security, and first responder wearable systems. The Shrike offers full-color 1280x720 resolution, a 40-degree field of view, and features like el...
Carnival Corporation posted a record third-quarter net income of $1.9 billion and all-time high revenues, driven by strong demand and disciplined cost control. Customer deposits and 2027 bookings reached record levels, supporting a positive outlook f...
